Aesthetic Medicine and Dermatology

Pigmentary disorders

Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites

Related Conference of Pigmentary disorders

June 22-23, 2026

October 03-04, 2022 Amsterdam, Netherlands

Theme: â€œCurrent Advancements and Novel Research in Dermatologyâ€.

Pigmentary disorders

Related Conference of Pigmentary disorders

28^th World Dermatology and Aesthetic Congress

27^th World Dermatology Congress

26^th European Dermatology Congress

9^th International Conference on Dermatology, Cosmetology and Plastic Surgery

25^th International Conference on Dermatology and Skin Care Sciences

9^th International Dermatology Conference: Skin and Body

16^th International Conference on Cosmetology and Dermatology

20^th International Conference on Alzheimers Disease & Dementia

4^th World Congress on Skin care, Dermatology and Allergic Diseases

9^th World Cosmetic and Dermatology Congress

31^th International Conference on Dermatology & Skin Care

29^th Global Summit on Dermatology, Skin Development and Ageing